Literature DB >> 30622396

Situation Awareness in Obsessive Compulsive Disorder and Their Relatives: an Endophenotype Study.

Didem Tezcan1, Selim Tümkaya2.   

Abstract

INTRODUCTION: It has been theorized that endophenotype models will help to understand the etiology of heterogeneous brain disorders such as obsessive-compulsive disorder (OCD). In this study, it was aimed to determine whether "situational awareness" impairments which can be defined as partially naturalistic working memory deficits, are an endofenotype for OCD.
METHODS: In this study, situational awareness (SA) task performances of 67 OCD patients, 50 their unaffected first-degree relatives, and 41 healthy controls who matched with regard to sex, age and years of education were measured to investigate endophenotypes in OCD. For this purpose, a visuospatial working memory test was used.
RESULTS: As a result, the relatives showed a task performance between patients with OCD and control group in both SA1 and SA2 tasks. Patients with OCD performed significantly worse than control group on SA1 single and dual task. On the other hand, there were no significant differences between relatives and patients of any SA assessment.
CONCLUSION: These results indicated that poor situational awareness may be a candidate endophenotype for OCD. Early perceptual dysfunctions such as poor performance on SA1 task can mediate the genetic risk for OCD.

Entities:  

Keywords:  Obsessive-compulsive disorder; endophenotype; neuropsychology; situation awareness; visuo-spatial working memory; working memory

Year:  2018        PMID: 30622396      PMCID: PMC6300842          DOI: 10.5152/npa.2017.20571

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  33 in total

1.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 3.  The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills.

Authors:  Naomi Chaytor; Maureen Schmitter-Edgecombe
Journal:  Neuropsychol Rev       Date:  2003-12       Impact factor: 7.444

4.  Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder.

Authors:  C R Savage; L Baer; N J Keuthen; H D Brown; S L Rauch; M A Jenike
Journal:  Biol Psychiatry       Date:  1999-04-01       Impact factor: 13.382

5.  Quality of life and disability in patients with obsessive-compulsive disorder.

Authors:  J Bobes; M P González; M T Bascarán; C Arango; P A Sáiz; M Bousoño
Journal:  Eur Psychiatry       Date:  2001-06       Impact factor: 5.361

6.  Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder.

Authors:  D-H Kang; J S Kwon; J-J Kim; T Youn; H-J Park; M S Kim; D S Lee; M C Lee
Journal:  Acta Psychiatr Scand       Date:  2003-04       Impact factor: 6.392

Review 7.  Understanding obsessive-compulsive disorder: focus on decision making.

Authors:  Paolo Cavedini; Alessandra Gorini; Laura Bellodi
Journal:  Neuropsychol Rev       Date:  2006-03       Impact factor: 7.444

8.  "Not just right experiences": perfectionism, obsessive-compulsive features and general psychopathology.

Authors:  Meredith E Coles; Randy O Frost; Richard G Heimberg; Josée Rhéaume
Journal:  Behav Res Ther       Date:  2003-06

9.  Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits.

Authors:  M M A Nielen; J A Den Boer
Journal:  Psychol Med       Date:  2003-07       Impact factor: 7.723

10.  Neurocognitive endophenotypes of obsessive-compulsive disorder.

Authors:  Lara Menzies; Sophie Achard; Samuel R Chamberlain; Naomi Fineberg; Chi-Hua Chen; Natalia del Campo; Barbara J Sahakian; Trevor W Robbins; Ed Bullmore
Journal:  Brain       Date:  2007-09-13       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.